Liv Pure Peptide Product: 5-AMINO-1MQ (ORAL)

Liv Pure Peptides 5-AMINO-1MQ (ORAL) (Nicotinamide N-methyltransferase (NNMT)) Category: Weight Loss $159.00 CAS# 6967-29-9 Formula: C7H10N4O1 Molecular Weight: 166.180 g/mol

5-Amino-1MQ (Oral) (60 capsules) a synthetic small molecule designed for research involving cellular metabolism, methylation processes, and biochemical pathways. This oral formulation is intended solely for laboratory use to facilitate studies across molecular and cellular biology disciplines.

This version is administered orally, distinguishing it from the injectable formulation, and is provided for applications where non-invasive delivery is preferred.

For Research Purposes Only – Not for Human Use or Consumption.

Out of Stock

Sizes

Liv Pure Peptides Products: 5-AMINO-1MQ (ORAL) 50mg

At Liv Pure Peptides, innovation meets purity. Our advanced research and rigorous quality standards deliver breakthrough peptide solutions for better health and science.

Shop Products

Products

Pages

Legal

Newsletter Signup

YOU MUST BE OVER 21 YEARS OLD TO USE THIS WEBSITE.

All products provided by Liv Pure are intended solely for in‑vitro laboratory research purposes. These materials are expressly forbidden for any form of human or animal use, ingestion, or administration, and all products are sold strictly for research, laboratory, or analytical purposes – not for human consumption.

The products offered on this platform are not formulated, designed, or intended to diagnose, cure, mitigate, treat, or prevent any diseases or medical conditions. Additionally, these statements have not been evaluated by the Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease.

All products are for Research and Development use only and are not for human consumption.

Liv Pure is a chemical supplier; LIV Pure Peptides is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor is it an outsourcing facility as defined under Section 503B of the Act.